Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First bovine respiratory disease vaccine for newborn calves
BOVILIS® INtranasal RSP™ Live vaccine is now licensed for use in calves from birth onwards.

MSD announces only BRD vaccine that can be administered in early life. 

MSD Animal Health has announced the first bovine respiratory disease (BRD) vaccine for newborn calves.

In a press release, the manufacturer said its new BOVILIS® INtranasal RSP™ Live vaccine is now licensed for use in calves from birth onwards. 

It is the only BRD vaccine that can be administered in early life – a significant advantage given that the sooner young calves can be protected from viral BRD and the harm it causes, the better.

An MSD Animal Health spokesperson said: “BOVILISâ INtranasal RSPä Live delivers the fastest on-farm protection of all the available pneumonia vaccines, with an onset of immunity after administration for BRSV of just six days (for calves vaccinated from the day of birth onwards) and five days (for calves vaccinated from the age of one week onwards). 

“Onset of immunity after administration for Pi3V is one week after vaccination. The duration of immunity is 12 weeks for both viruses.”

BRD is caused by bovine respiratory syncytial virus (BRSV) and parainfluenza virus 3 (Pi3).

Early and fast protection against pneumonia is important. Indeed, research published in the Journal of Dairy Science shows that replacement heifers that do not suffer pneumonia while they are calves produce more than 500 kg more milk during their first lactation. 

“BOVILIS® INtranasal RSP™ Live also has significant practical usage benefits in that it can now be used on farm at the same time as other early life interventions associated with newborn calves – for example, colostrum/first milk feeding, navel management, tagging, jacketing and necessary pen movements,” the spokesperson continued.

“Additionally, BOVILIS® INtranasal RSP™ Live can be used up to six hours after mixing with the solvent, which is the longest of all the available intranasal vaccines for these pathogens. It is supplied as a farm-friendly, easy-to administer nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility an easy-clean injector and nozzle kit is available for vaccinating multiple animals.”

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.